Chinese Firms Seek Singapore Listings Amid US-China Trade Tensions

At least five major Chinese companies are preparing to list on the Singapore Exchange (SGX) within the next 12 to 18 months, as geopolitical friction between Beijing and Washington drives firms to explore alternative financial hubs. The cohort includes a state-backed energy group, a healthcare conglomerate, and a Shanghai-based biotech firm—all reportedly considering dual listings or private placements.

The pivot to Southeast Asia reflects a strategic diversification play. With US tariffs on Chinese goods reaching 145% at the height of trade hostilities, companies are building optionality beyond traditional Wall Street gateways. Singapore’s neutral jurisdiction and growing capital markets depth make it an increasingly viable springboard for regional expansion.